DexCom, Inc. - Common Stock (NQ:DXCM)

A quality compounder is a business that not only sports durable competitive advantages but also builds on its success by consistently reinvesting its profits...

3 quality compounders with promising prospects

November 01, 2026

Medical device company DexCom (NASDAQ:DXCM) reported revenue ahead of Wall Street’s expectations in Q3 2026, with sales up 11.2% year on year to $1.34 billio...

S&P 500 Unusual Volume Movers for Oct. 30, 2026 ↗

October 30, 2026

Via Chartmill

Topics Stocks

DXCM Q3 deep dive: clinical momentum and new product launches support growth trajectory

October 30, 2026

Record patient starts and type 2 diabetes share gains fuel 11% revenue growth.

DexCom (NASDAQ:DXCM): Affordable Growth at a Reasonable Valuation ↗

October 13, 2026

Via Chartmill

DexCom (NASDAQ:DXCM): Strong Growth Paired With a High-Quality Technical Setup ↗

October 02, 2026

Via Chartmill

Dexcom (DXCM) Q3 2026 Earnings Call Transcript ↗

October 30, 2026

Via The Motley Fool

Topics Earnings

What DexCom (DXCM) Said on Its Q3 Earnings Call ↗

October 29, 2026

DexCom (NASDAQ:DXCM) reported third-quarter 2026 revenue of $1.34 billion, up 11% from a year earlier on both a reported and organic basis, as U.S. growth, market-share gains and manufacturing...

Via MarketBeat

Topics Earnings Initial Public Offering

2 Stocks That Could Quietly Become Big Winners in the Artificial Intelligence (AI) Revolution ↗

October 29, 2026

These aren’t top AI stocks, but the technology is helping improve their businesses.

Via The Motley Fool

Topics Artificial Intelligence

DexCom (NASDAQ:DXCM) beats Q3 2026 sales expectations

October 29, 2026

Medical device company DexCom (NASDAQ:DXCM) reported Q3 2026 results beating Wall Street’s revenue expectations, with revenue up 11.2% year on year to $1.34 ...

Dexcom Reports Third Quarter 2026 Financial Results

October 29, 2026

Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch in Canada in November

October 28, 2026

Medical device company DexCom (NASDAQ:DXCM) will be reporting results this Thursday after the bell. Here’s what investors should know. DexCom beat analysts’ ...

What to expect from DexCom’s (DXCM) Q3 earnings

October 27, 2026

Landmark Dexcom CONNECT Study Published in The New England Journal of Medicine, Redefining the Standard of Care for People with Type 2 Diabetes Not on Insulin

S&P 500 Unusual Volume Movers in Today's Session ↗

October 22, 2026

Via Chartmill

Topics Stocks

S&P 500 Top Movers: Oct. 21, 2026 US Session ↗

October 21, 2026

Via Chartmill

Topics Stocks

S&P 500 Top Movers on Oct. 21, 2026: Supermicro Leads Gainers, Dexcom Leads Losers ↗

October 21, 2026

Via Chartmill

Topics Stocks

These S&P500 stocks that are showing activity before the opening bell on Thursday. ↗

October 15, 2026

Via Chartmill

October 14, 2026

Dexcom Schedules Third Quarter 2026 Earnings Release and Conference Call for October 29, 2026 at 4:30 p.m. Eastern Time

October 07, 2026

Dexcom U Enters Season 5 With a Record Roster and Evidence That Diabetes Stigma Among Young Athletes Is Fading

Uncover the latest developments among S&P500 stocks in today's session. ↗

October 06, 2026

Via Chartmill

October 06, 2026

Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care

Which S&P500 stocks are moving on Tuesday? ↗

October 06, 2026

Via Chartmill

Tuesday's session: gap up and gap down stock in the S&P500 index ↗

October 06, 2026

Via Chartmill

September 28, 2026

Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new are...

2 Large-Cap Stocks with Exciting Potential and 1 Facing Headwinds

September 25, 2026

Oura's IPO targets a $12.8B-$14.1B valuation, pricing shares at $40-$44 ahead of its Nasdaq debut, backed by Eli Lilly interest and strong subscription revenue growth.

Oura’s $15.6 Billion IPO Is Betting Investors See More Than a Smart Ring ↗

September 22, 2026

Via MarketBeat

Topics Initial Public Offering

2 Nasdaq 100 Stocks for Long-Term Investors and 1 We Turn Down

September 21, 2026

The Nasdaq 100 (^NDX) is home to some of the biggest success stories in tech and growth investing. However, certain stocks in the index face challenges like ...

Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord...

September 18, 2026

Dexcom Promotes Jereme Sylvain to Chief Operating Officer

September 14, 2026

Dexcom Appoints Glenn Boehnlein to Board of Directors

September 10, 2026